Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts

Despite substantial progress in treatment of T-cell acute lymphoblastic leukemia (T-ALL), mortality remains relatively high, mainly due to primary or acquired resistance to chemotherapy. Further improvements in survival demand better understanding of T-ALL biology and development of new therapeutic...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Haematologica
Prif Awduron: Agnusdei, Valentina, Minuzzo, Sonia, Pinazza, Marica, Gasparini, Alessandra, Pezzè, Laura, Amaro, Adriana Agnese, Pasqualini, Lorenza, Bianco, Paola Del, Tognon, Martina, Frasson, Chiara, Palumbo, Pietro, Ciribilli, Yari, Pfeffer, Ulrich, Carella, Massimo, Amadori, Alberto, Indraccolo, Stefano
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Ferrata Storti Foundation 2020
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7193477/
https://ncbi.nlm.nih.gov/pubmed/31467126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.217687
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg